Ryo Kubota, MD, PhD

Representative Executive Officer, Chairman, President and Chief Executive Officer

Prior to founding Acucela in 2002, Dr. Kubota worked in the ophthalmology field, including serving as a faculty member at Keio University and at the University of Washington School of Medicine. Dr. Kubota holds an MD and a PhD in medicine from Keio University. There, he discovered the glaucoma gene, myocilin, a discovery that earned him the Suda Award for his contribution to the field of neurodegenerative retinal disease. He was board certified in ophthalmology by the Japanese Ophthalmological Society in 1996 and is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Japanese Ophthalmology Society, Keio Medical Society, the American Chamber of Commerce in Japan, and the America-Japan Society, Inc. Since 2008, Dr. Kubota has been a director of the Japan-America Society of the State of Washington. He was appointed as Foresight Advisory Group Member, Department of Pharmacology, Case Western Reserve University in 2012. In 2014, Dr. Kubota was appointed to the National Bureau of Asian Research Board of Directors, and a visiting professor at School of Medicine, Keio University. Since 2015, he has been an Advisory member for The Japanese Association of Medical University Network of Technology Transfer.

Hiroki Maekawa

Chief Financial Officer

Mr. Maekawa joined Kubota Pharmaceutical Holdings in June 2018. Prior to that, from 2013 to 2018, he was Chief Financial Officer for CEOLIA Pharma, a privately held pharmaceutical company focusing on ENT (Ear, Nose and Throat), and, he became a Board member in 2014. From 2009 through 2013, he was Chief Financial Officer for SymBio Pharmaceuticals, a Japanese biotech company specializing in cancer, immune diseases and hematology. He was also a Board member and Senior Executive Officer. He successfully led SymBio to an IPO in 2011. He was Head of Corporate Planning at Sosei in 2005, and became Sosei Group's Representative Executive Officer and Vice President, and Representative Director in 2006. From 1990 to 2005, he was responsible for Asset Management and Corporate Sales at Nippon Life Insurance Company where he began his career in finance.

He has over 10 years of executive officer experience as CFO and COO in biotech and pharmaceutical companies. He has a strong understanding of finance, financial analysis, business planning, healthcare business and organizational management.

CMA (Chartered Member of the Securities Analysts Association of Japan)
SMEC (Certified consultant for Small and Medium sized Enterprise)
Bachelor of Economics from Doshisha University (1990)

Board of Directors

Ryo Kubota, MD, PhD

Representative Executive Officer, Chairman, President and Chief Executive Officer, Kubota Pharmaceutical Holdings Co., Ltd.

Chairman, President and Chief Executive Officer, Acucela Inc.

Shintaro Asako

Chief Financial Officer, DeNA Co., Ltd.

Shiro Mita, PhD

President and Chief Executive Officer, M's Science Corporation

Eisaku Nakamura

Corporate Auditor, Koinobori Associates Inc.

Robert Takeuchi

President, RT Consulting, Inc.